首页> 外国专利> PREDICTION METHOD OF EFFICIENCY immunotherapy based on evaluation of the expression level of cytokine mRNA in a tissue KIDNEY CANCER

PREDICTION METHOD OF EFFICIENCY immunotherapy based on evaluation of the expression level of cytokine mRNA in a tissue KIDNEY CANCER

机译:基于肾癌组织中细胞因子mRNA表达水平评估的高效免疫治疗预测方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to the field of medicine. Claimed is a method of determining sensitivity of kidney cancer to immunotherapy after performing nephrectomy, including diagnosis verification, performing nephrectomy of kidney cancer, sampling of tumour and normal kidney tissue to determine a level of expression of cytokines IL-4, IL-6, IL-10, TGFβ and calculation of ratio of level of cytokine expression in tumour and normal kidney tissue. If the level of cytokine expression in tumour tissue of kidney is higher than normal, therapy is considered to be indicated.;EFFECT: invention makes it possible to determine sensitivity of kidney cancer to immunotherapy on the basis of the data of cytokine expression in tumour tissue.;2 tbl, 1 ex
机译:技术领域本发明涉及医学领域。要求保护的是在进行肾切除术之后确定肾癌对免疫疗法的敏感性的方法,包括诊断验证,进行肾癌的肾切除术,对肿瘤和正常肾脏组织进行采样以确定细胞因子IL-4,IL-6,IL的表达水平-10,TGFβ和肿瘤与正常肾脏组织中细胞因子表达水平之比的计算。如果肾肿瘤组织中细胞因子表达水平高于正常水平,则认为有治疗的必要。效果:本发明使得根据肿瘤组织中细胞因子表达的数据确定肾癌对免疫疗法的敏感性成为可能。 。; 2 tbl,1 ex

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号